Mesenchymal stromal cells implantation in combination with platelet lysate product is safe for reconstruction of human long bone nonunion

Narges, Labibzadeh; Mohsen, Emadedin; Roghayeh, Fazeli; Fatemeh, Mohseni; Seyedeh Esmat, Hosseini; Reza, Moghadasali; Soura, Mardpour; Vajiheh, Azimian; Maede Ghorbani, Liastani; Ali Mirazimi, Bafghi; Mohamadreza Baghaban, Eslaminejad; Nasser, Aghdami

Narges, Labibzadeh; Mohsen, Emadedin; Roghayeh, Fazeli; Fatemeh, Mohseni; Seyedeh Esmat, Hosseini; Reza, Moghadasali; Soura, Mardpour; Vajiheh, Azimian; Maede Ghorbani, Liastani; Ali Mirazimi, Bafghi; Mohamadreza Baghaban, Eslaminejad; Nasser, Aghdami.

Cell Journal [Yakhteh]. 2016; 18 (3): 302-309

en Inglés | IMEMR | ID: emr-183764

ABSTRACT

ABSTRACT

Objective:

nonunion is defined as a minimum of 9 months since injury without any visible progressive signs of healing for 3 months. Recent literature has shown that the application of mesenchymal stromal cells is safe, in vitro and in vivo, for treating long bone nonunion. The present study was performed to investigate the safety of mesenchymal stromal cell [MSC] implantation in combination with platelet lysate [PL] product for treating human long bone nonunion

Buscar en Google

Imprimir

XML

Índice: IMEMR (Mediterraneo Oriental) Tipo de estudio: Ensayo Clínico Controlado Idioma: Inglés Revista: Cell J. [Yakhteh] Año: 2016

Similares

MEDLINE

LILACS

LIS

Buscar en Google

Imprimir

XML

Índice: IMEMR (Mediterraneo Oriental) Tipo de estudio: Ensayo Clínico Controlado Idioma: Inglés Revista: Cell J. [Yakhteh] Año: 2016